Tag: Central Drugs Standard Control Organisation
BaroPace gets CDSCO approval for RelieveHFpEF-II clinical trial in India
BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been granted approval by the Central Drugs Standard ... Read More
AstraZeneca Pharma India gets Dapagliflozin 10mg import and market permission from CDSCO
AstraZeneca Pharma India has secured an import and market permission for Dapagliflozin (Forxiga) tablets of 10 mg from India’s Central Drugs Standard Control Organisation (CDSCO), ... Read More
Bharat Parenterals gets license and authorization for Favipiravir oral suspension for Covid treatment
Bharat Parenterals said that it has secured the license and authorization from Drugs Controller General of India (DCGI) and Central Drugs Standard Control Organisation (CDSCO) ... Read More
Glenmark Pharmaceuticals launches FabiFlu for COVID-19 treatment in India
Glenmark Pharmaceuticals has secured approval from India to launch Japan-based Fujifilm's antiviral drug favipiravir under the brand name FabiFlu for the treatment of COVID-19 in ... Read More